Revefenacin Impurity 31 | CAS 1821022-36-9 - Request Quote
Revefenacin Impurity 31
| SZ CAT No: | SZ-R043042 |
| CAS No | 1821022-36-9 |
| Mol.F. | C8H6Br2O |
| Mol.Wt. | 277.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Revefenacin Impurity 31 is chemically 4-(Dibromomethyl)benzaldehyde. Revefenacin Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Revefenacin Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Revefenacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1821022-36-9
Purchase 1821022-36-9
Order 1821022-36-9
Enquire 1821022-36-9
price of 1821022-36-9
1821022-36-9 Supplier
1821022-36-9 Manufacturer
1821022-36-9 Exporter
buy high quality Revefenacin Impurity 31
Purchase Revefenacin Impurity 31
Revefenacin Impurity 31 suppliers
Revefenacin Impurity 31 manufacturers
Revefenacin Impurity 31 price
Order Revefenacin Impurity 31
Enquire Revefenacin Impurity 31
Revefenacin Impurity 31 cost
Revefenacin Impurity 31 Supplier
Revefenacin Impurity 31 Distributor
Revefenacin Impurity 31 for Method Validation
Revefenacin Reference Standard
Revefenacin Impurity 31 for ANDA Filing
Revefenacin Impurity 31 for Forced Degradation Studies
Revefenacin Impurity 31 Identification Standards
Revefenacin Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.